Drug class
Diagnostic radiopharmaceutical precursor; human serum albumin macroaggregates for technetium-99m labelling
Mechanism of action
Albumin macroaggregate particles, when labelled with technetium-99m, are trapped transiently in pulmonary capillaries and arterioles in proportion to regional blood flow. The resulting distribution of gamma emissions permits scintigraphic assessment of pulmonary perfusion.
General use cases
- After radiolabelling with technetium-99m, used for lung perfusion scintigraphy as an adjunct in evaluation of pulmonary perfusion in adults and children.
- After radiolabelling, can be used for peritoneovenous shunt scintigraphy to assess shunt patency in adults, according to the product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
